Software AG

  • WKN: A2GS40
  • ISIN: DE000A2GS401
  • Land: Germany

Nachricht vom 31.01.2019 | 00:55

Software AG adopts new strategic direction / Outlook 2019 / Medium term financial ambitions

Software AG / Key word(s): Strategic Company Decision/Forecast
Software AG adopts new strategic direction / Outlook 2019 / Medium term financial ambitions

31-Jan-2019 / 00:55 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of insider information in accordance with Article 17 of Regulation (EU) No 596/2014

Software AG adopts new strategic direction / Outlook 2019 / Medium term financial ambitions


The Management Board of Software AG (MDAX, ISIN DE000A2GS401 / SOW) adopted the following resolutions:

1. New strategic direction (Project Helix)

The strategic reorientation has the goal of accelerating revenue growth while both achieving higher recurring revenue and maintaining high profitability. As part of this strategy, the product portfolio will be focused on growth segments and Sales and Marketing activities in core markets will be increased. For this purpose, EUR20 to EUR30 million in new net investment will be made in the new business model in 2019. Furthermore, in 2020, while the business volume will continue to grow, the licensing model will be changed in such a way that revenue will no longer be recognized immediately, but spread over several years ("Subscription").

2. Outlook 2019

In view of the above investments, the outlook for 2019 is as follows:

Outlook for Fiscal Year 2019    
  FY 2018
in EUR mn
FY 2019 Outlook
as of January 31, 2019 as %
DBP revenue 464.7 -
DBP excl. DBP Cloud & IoT 434.4 +3 to +71
DBP Cloud & IoT 30.3 +75 to +1251
A&N revenue 218.3 -5 to 01
Operating margin
(EBITA, non-IFRS)2
31.5% 28.0 to 30.0
     
1 at constant currency

2 adjusted for non-operating factors (see non-IFRS earnings definition in annual report 2017 from p. 46 onward)
 

3. Medium term financial ambitions

Whilst the product business will continue to grow, the change in the licensing model will, in 2020 (the first year of full application), have an effect on the reported operating EBITA margin (non-IFRS) compared to the previous year (2019) of no more than -2 percentage points.

From 2021 onwards, business growth should once again be reflected in sales and in a rising EBITA margin (non-IFRS) that is expected to reach more than 30% over the medium term. In order to be able to better assess the operational development of the company in 2020 and the following years, additional industry-standard metrics (Annual recurring revenue (ARR), bookings and operating cash flow) will be reported from 2019, in addition to the IFRS key figures.

These resolutions of the Management Board are subject to the approval of the Supervisory Board.

Darmstadt, 31.01.2019

The Management Board
Software AG, Uhlandstr. 12, 64297 Darmstadt



Contact:
Person making the notification:
Frederic Freichel
Manager Investor Relations

Email: frederic.freichel@softwareag.com
Tel: +49 6151 92 1106

31-Jan-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

01. Dezember 2021